Kisspeptin-10
peptide · headlineResearch use onlyActivates KISS1 receptors in the hypothalamus, stimulating GnRH release and increasing LH (Luteinizing Hormone) & FSH (F
Overview
Kisspeptin-10 is a potent regulator of reproductive hormone signaling that stimulates GnRH secretion from the hypothalamus, which in turn increases LH and FSH levels to support testosterone, estrogen, and fertility. It has been studied for its role in treating hypogonadism, improving libido, and optimizing reproductive cycles. Emerging research also suggests metabolic benefits through its effects on insulin sensitivity and fat regulation.
How it works
- Activates KISS1 receptors in the hypothalamus, stimulating GnRH release and increasing LH (Luteinizing Hormone) & FSH (Follicle-Stimulating Hormone) secretion.
- Enhances gonadal steroid production, leading to increased testosterone and estrogen levels.
- May improve metabolic health, influencing leptin, insulin signaling, and adipocyte function.
Dosing
Clinical research doses: 1–10 mcg/kg IV or SQ as single bolus. Diagnostic use: 1 mcg/kg IV to assess gonadotropin response. Therapeutic research: 4–10 mcg/kg SQ daily for 2–4 weeks in reproductive endocrine studies. Monitor LH, FSH, testosterone, and estrogen.
Caution: Clinical studies use doses of 0.1–1.0 μg/kg via IV or SubQ routes. These studies are investigational and not for general use.
Cycling
- Inject 0.4 mcg/kg SubQ daily for 2–4 weeks, followed by reevaluation of hormonal markers. Cycle every 6–12 weeks depending on reproductive goals. Monitor for changes in LH, FSH, testosterone, or estrogen levels.
Side effects
- Common
- Transient flushing (warmth and redness, face)
- Mild headache, nausea, lightheadedness
- Warnings
- Only short-term dosing studied in humans
Stacking & combinations
- With
LL-37
- Benefit
Enhanced endocrine function
Lifestyle support
- Diet
Adequate nutrition and healthy body weight for endogenous hormone production.
- Sleep
Sleep and stress management — HPG axis is sensitive to both. Monitor reproductive function changes.
- Timing
Consistent injection schedule.
- Exercise
Moderate activity as tolerated.
Research studies
Studies summarized for educational purposes only. Inclusion does not imply human use; referenced research was conducted in vitro, in animal models, or in regulated clinical trials.
Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men
George JT, et al. J Clin Endocrinol Metab. 2011;96(8):E1228-36. View source ↗
In healthy men, intravenous bolus kisspeptin-10 produced a rapid, dose-dependent rise in serum LH, with maximal stimulation at 1 ug/kg. Continuous lower-dose infusion (1.5 ug/kg/h) increased mean LH, raised LH pulse frequency (approximately 0.7 to 1.0 pulses/h), and increased secretory burst mass, with a downstream rise in testosterone. The data indicate kisspeptin-10 acts upstream of GnRH to augment pulsatile gonadotropin secretion.
When healthy men were given kisspeptin-10 into a vein, their luteinizing hormone (LH) — the pituitary signal that drives testosterone — rose quickly and in proportion to the dose. A slow infusion also made LH pulses come more often and testosterone rise. This was an early human study showing the peptide can switch on the reproductive hormone axis.
The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans
Jayasena CN, et al. J Clin Endocrinol Metab. 2011;96(12):E1963-72. View source ↗
Kisspeptin-10 stimulated gonadotropin (LH and FSH) release in healthy men across doses. In women, the gonadotropin response was strongly dependent on menstrual cycle phase: robust during the preovulatory phase but largely absent during the follicular phase. This demonstrates sexual dimorphism and sex-steroid/cycle-dependent sensitivity of the human hypothalamic-pituitary-gonadal axis to kisspeptin-10.
Kisspeptin-10 reliably raised reproductive hormones in men, but in women its effect depended heavily on where they were in their menstrual cycle — working near ovulation but not in the early follicular phase. This showed that men and women respond differently, and that the female response shifts with the hormonal state of the cycle.
Kisspeptin modulates sexual and emotional brain processing in humans
Comninos AN, et al. J Clin Invest. 2017;127(2):709-719. View source ↗
In a randomized, double-blind, placebo-controlled crossover fMRI study of 29 healthy heterosexual young men, kisspeptin administration enhanced activity in limbic and paralimbic brain structures in response to sexual and couple-bonding images. The degree of enhancement correlated with psychometric measures of reward, drive, and reduced sexual aversion, and kisspeptin attenuated negative mood. Findings suggest a central role for kisspeptin in integrating sexual and emotional processing beyond its endocrine effects. (This study used the kisspeptin-54 isoform.)
Brain scans of healthy young men showed that kisspeptin boosted activity in emotional and reward-related brain regions when they viewed sexual and romantic images, and it slightly improved mood. The effects tracked with how the men rated their own arousal and mood. This suggested kisspeptin influences the emotional and sexual brain, not just reproductive hormones, and hinted at possible use in psychosexual disorders.
Verified citations
2 · PubMed-checked- The roles of kisspeptin and neurokinin B in GnRH pulse generation in humans.reviewPMID 34962670 ↗
- Kisspeptin-10 stimulates release of LH and testosterone in male goats.preclinicalPMID 22694333 ↗
Reconstitution calculator
Subcutaneous (SQ)= 0.001 mL on a U-100 insulin syringe
Assumes a U-100 insulin syringe (100 units = 1 mL). This is a preparation aid, not a protocol — dose and route are the prescriber's decision. Refrigerate at 2–8 °C (35.6–46.4 °F); stable up to ~4 weeks; avoid freeze–thaw
Chemistry & PK
- Sequence
- YNWNSFGLRF-NH2
- Half Life
- Around 30 minutes in plasma.
- Degradation
- Rapidly degraded enzymatically in plasma.
- Molecular Weight
- 1302.4
- Molecular Formula
- C63H83N17O14
- Tissue Specificity
- Primarily affects the hypothalamic-pituitary-gonadal axis.
Bioavailability
- Oral
- Poor bioavailability due to instability in the gastrointestinal tract.
- Subq
- High absorption with sustained release effect.
Storage & handling
- Lyophilized
freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles
- Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); stable up to ~4 weeks; avoid freeze–thaw
Legal / compounding
- EU
- Not Approved
- FDA
- Not Approved
- Canada
- Not Approved
- Australia
- Not Approved
Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.